VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $799,658 | -10.5% | 29,716 | +0.1% | 0.33% | -4.6% |
| Q2 2023 | $893,846 | -6.8% | 29,686 | +0.2% | 0.35% | -12.4% |
| Q1 2023 | $958,725 | +25.0% | 29,636 | +10.8% | 0.40% | +20.0% |
| Q4 2022 | $766,827 | +24.1% | 26,756 | +4.5% | 0.33% | +18.3% |
| Q3 2022 | $618,000 | -12.6% | 25,606 | -0.8% | 0.28% | -7.9% |
| Q2 2022 | $707,000 | -28.2% | 25,804 | +0.4% | 0.30% | -12.9% |
| Q1 2022 | $985,000 | +26.8% | 25,689 | +5.9% | 0.35% | +35.9% |
| Q4 2021 | $777,000 | +9.4% | 24,254 | +0.6% | 0.26% | +6.7% |
| Q3 2021 | $710,000 | -6.7% | 24,099 | +7.5% | 0.24% | -3.6% |
| Q2 2021 | $761,000 | +73.0% | 22,409 | +65.4% | 0.25% | +56.6% |
| Q1 2021 | $440,000 | -79.6% | 13,552 | -77.4% | 0.16% | -6.5% |
| Q4 2020 | $2,160,000 | +7.5% | 60,005 | +16.8% | 0.17% | -20.2% |
| Q3 2020 | $2,010,000 | +5.2% | 51,375 | -1.3% | 0.21% | +0.5% |
| Q2 2020 | $1,910,000 | +695.8% | 52,050 | +400.0% | 0.21% | +19.8% |
| Q1 2020 | $240,000 | -21.3% | 10,410 | 0.0% | 0.18% | +14.2% |
| Q4 2019 | $305,000 | +6.3% | 10,410 | -3.2% | 0.16% | +6.2% |
| Q3 2019 | $287,000 | +2.9% | 10,750 | -1.5% | 0.15% | +5.0% |
| Q2 2019 | $279,000 | +13.9% | 10,910 | 0.0% | 0.14% | +13.0% |
| Q1 2019 | $245,000 | +6.5% | 10,910 | 0.0% | 0.12% | -7.5% |
| Q4 2018 | $230,000 | -77.2% | 10,910 | -80.0% | 0.13% | +43.0% |
| Q3 2018 | $1,010,000 | -16.9% | 54,550 | 0.0% | 0.09% | -17.7% |
| Q2 2018 | $1,215,000 | +380.2% | 54,550 | +373.9% | 0.11% | -10.3% |
| Q1 2018 | $253,000 | -6.3% | 11,510 | -0.9% | 0.13% | -2.3% |
| Q4 2017 | $270,000 | +1.1% | 11,610 | 0.0% | 0.13% | +4.0% |
| Q3 2017 | $267,000 | +4.3% | 11,610 | 0.0% | 0.12% | +6.9% |
| Q2 2017 | $256,000 | -80.3% | 11,610 | -79.6% | 0.12% | -4.1% |
| Q1 2017 | $1,300,000 | +446.2% | 56,975 | +400.0% | 0.12% | +10.0% |
| Q4 2016 | $238,000 | -13.5% | 11,395 | +9.6% | 0.11% | -17.9% |
| Q3 2016 | $275,000 | -4.5% | 10,395 | 0.0% | 0.13% | -12.4% |
| Q2 2016 | $288,000 | – | 10,395 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |